Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
1p/19q Codeletion
18%
8-domain
18%
Acidic Properties
18%
Actin Bundles
18%
Adult Glioblastoma
18%
Alternative Splicing
18%
Asthmatic Airway
18%
ATM Kinase
18%
Autophagy
18%
B-CLL
18%
Cancer Therapy
21%
Cell Cycle Genes
40%
Cell Migration
18%
CENP-A
18%
Centromere
23%
Centromeric Stability
18%
Chromatin
18%
Chromatin Dynamics
25%
Cigarette Smoking
18%
Clinical Characterization
18%
Clinical Impact
37%
CpG Island Methylator Phenotype
18%
CRISPR Screen
18%
Diffuse Glioma
37%
DNA Damage Response
39%
DNA Damage Response Genes
18%
DNA Double-strand Breaks
37%
DNA Repair
97%
DNA Repair Capacity
26%
DNA Repair Factors
22%
DNA Repair Genes
18%
DNA Repair Pathways
14%
Dynamic Repair
18%
Endosome
18%
Enzymatic Activity
18%
Eviction
18%
Gene Expression
35%
Gene Expression Profile
18%
Gene Expression Studies
18%
Gene Signature
64%
Genome Stability
27%
Genomic Instability
13%
Genotoxic Treatments
26%
Glioblastoma
100%
Glioblastoma Cell Line
23%
Glioblastoma Cells
18%
Glioma
48%
Glioma Patients
24%
Glycosyltransferase
18%
Head-and-neck Cancer
18%
High-grade Glioma
44%
Histone Deacetylase Inhibitor (HDACi)
18%
Histone H3
21%
Immunological Therapy
18%
Innate Immune Response
18%
Interactome
18%
International Journals
18%
Ionizing Radiation
19%
Isocitrate Dehydrogenase 1 (IDH1)
18%
LIM Protein
18%
Long Non-coding RNA (LncRNA)
18%
Longitudinal Analysis
18%
Lung
18%
Macrophages
18%
Metformin
18%
MGCD0103
18%
Molecular Evolution
18%
Molecular Science
18%
Mouse Bone Marrow Cells
18%
NEIL3
18%
NEIL3 DNA Glycosylase
18%
O6-methylguanine-DNA Methyltransferase
18%
Oncogenesis
15%
Patient Biopsies
18%
Pediatric
37%
Pediatric Glioblastoma
18%
Personalized Treatment
18%
Primary Glioblastoma
18%
Prognostic Value
43%
R-loops
18%
RAD52
25%
Radiotherapy
14%
Recurrent Glioblastoma
18%
Regulatory Loop
18%
Replication Stress
18%
Respiratory Tract
18%
Response to Immunotherapy
18%
RNA Interference
20%
RNA Interference Screen
18%
Sensibility
18%
Smokers
18%
Targets for Therapy
18%
Telomeric DNA
18%
Temozolomide
69%
Therapeutic Implications
43%
TLR3
18%
Treatment Resistance
23%
Tumor
16%
Tumor Immunity
39%
XAB2
18%
Biochemistry, Genetics and Molecular Biology
Actin
18%
Alpha Thalassemia/Mental Retardation X-Linked
21%
Alternative Splicing
18%
Anticancer
6%
Biological Phenomena and Functions Concerning the Entire Organism
6%
BRCA1
9%
C-Terminus
18%
Cancer Cell
7%
Candidate Gene
10%
Carcinogenesis
28%
Cell Cycle
46%
Cell Migration
18%
CENPA
6%
Centromere
32%
Chaperone
15%
Chromatin
51%
Chromosome
6%
Chromosome Instability
8%
Chromosome Segregation
6%
Cigarette Smoking
12%
CpG Island
18%
CRISPR
18%
CRISPR/Cas9
6%
Differentially Expressed Gene
6%
DNA Damage
6%
DNA Damage Response
57%
DNA Glycosylase
18%
DNA Repair
93%
DnaA
37%
Double-Strand DNA Break
37%
Downregulation
6%
Drug Resistance
5%
Drug Response
9%
Enzyme Activity
18%
Expression Level
5%
Gene Expression
68%
Gene Expression Profiling
46%
Gene Function
6%
Gene Signature
34%
Genetic Screen
6%
Genome Instability
41%
Genotyping
6%
Glycosyltransferase
18%
Histone
13%
Histone H3
12%
Homologous Recombination
14%
Innate Immunity
18%
Interactome
18%
Isocitrate Dehydrogenase
18%
Kinase
18%
Kinetochore
6%
Long Noncoding RNA
18%
Macrophage
18%
Non-Homologous End Joining
9%
Nucleosome
21%
O-6-Methylguanine-DNA Methyltransferase
18%
Overall Survival
6%
PARP1
6%
Pediatrics
42%
Peptide
9%
Phosphotransferase
18%
Posttranslational Modification
6%
Progression Free Survival
7%
R-Loop
18%
RAD51
18%
RAD52
28%
Repair Gene
18%
RNA
18%
RNA Interference
18%
RNA Sequencing
9%
RNAI
18%
Telomere
11%
Telomere Homeostasis
7%
TLR3
18%
Toll-Like Receptor
7%
Transcription
22%
Tumor Immunity
18%
Upregulation
5%